257 related articles for article (PubMed ID: 32493105)
1. Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease.
Daull P; Amrane M; Ismail D; Georgiev G; Cwiklik L; Baudouin C; Leonardi A; Garhofer G; Garrigue JS
J Ocul Pharmacol Ther; 2020; 36(6):355-365. PubMed ID: 32493105
[TBL] [Abstract][Full Text] [Related]
2. Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease.
Labetoulle M; Garhöfer G; Ismail D; Garrigue JS; Amrane M; Guillon M; Aragona P; Baudouin C
Acta Ophthalmol; 2024 Jun; 102(4):382-390. PubMed ID: 38294079
[TBL] [Abstract][Full Text] [Related]
3. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
Rolando M; Merayo-Lloves J
Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
[TBL] [Abstract][Full Text] [Related]
4. Topical cyclosporine A therapy for dry eye syndrome.
de Paiva CS; Pflugfelder SC; Ng SM; Akpek EK
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010051. PubMed ID: 31517988
[TBL] [Abstract][Full Text] [Related]
5. Relevance of Lipid-Based Products in the Management of Dry Eye Disease.
Garrigue JS; Amrane M; Faure MO; Holopainen JM; Tong L
J Ocul Pharmacol Ther; 2017 Nov; 33(9):647-661. PubMed ID: 28956698
[TBL] [Abstract][Full Text] [Related]
6. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
[TBL] [Abstract][Full Text] [Related]
7. Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease.
Labetoulle M; Benitez-Del-Castillo JM; Barabino S; Herrero Vanrell R; Daull P; Garrigue JS; Rolando M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269576
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study.
Sacchetti M; Lambiase A; Schmidl D; Schmetterer L; Ferrari M; Mantelli F; Allegretti M; Garhoefer G
Br J Ophthalmol; 2020 Jan; 104(1):127-135. PubMed ID: 30944103
[TBL] [Abstract][Full Text] [Related]
9. Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?
Essa L; Laughton D; Wolffsohn JS
Cont Lens Anterior Eye; 2018 Feb; 41(1):60-68. PubMed ID: 28811095
[TBL] [Abstract][Full Text] [Related]
10. Rationale for 24-hour management of dry eye disease: A review.
Guillon M; Shah S
Cont Lens Anterior Eye; 2019 Apr; 42(2):147-154. PubMed ID: 30497903
[TBL] [Abstract][Full Text] [Related]
11. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.
Srinivasan S; Williams R
Clin Ophthalmol; 2022; 16():3311-3326. PubMed ID: 36237486
[TBL] [Abstract][Full Text] [Related]
12. Autologous serum eye drops for dry eye.
Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
[TBL] [Abstract][Full Text] [Related]
13. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.
Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG
Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956
[TBL] [Abstract][Full Text] [Related]
15. Tear-film-oriented diagnosis for dry eye.
Yokoi N; Georgiev GA
Jpn J Ophthalmol; 2019 Mar; 63(2):127-136. PubMed ID: 30783943
[TBL] [Abstract][Full Text] [Related]
16. Effect of a formulated eye drop with
Tan J; Jia T; Liao R; Stapleton F
Br J Ophthalmol; 2020 Oct; 104(10):1373-1377. PubMed ID: 31949092
[TBL] [Abstract][Full Text] [Related]
17. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
[No Abstract] [Full Text] [Related]
18. Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus ≥ 55 years.
Mateo-Orobia AJ; Del Prado Sanz E; Blasco-Martínez A; Pablo-Júlvez LE; Farrant S; Chiambaretta F
Cont Lens Anterior Eye; 2023 Aug; 46(4):101845. PubMed ID: 37117131
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Therapeutic Capability of Emustil Drops against Tear Film Complications under Dry Environmental Conditions in Healthy Individuals.
Abusharha A; Pearce IE; Afsar T; Razak S
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512109
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
